IceCure Medical Reports Q1 2025 Financial Results
Ticker: ICCM · Form: 6-K · Filed: May 28, 2025 · CIK: 1584371
Sentiment: neutral
Topics: financial-results, 6-K, press-release
Related Tickers: ICCM
TL;DR
IceCure Medical dropped Q1 2025 results on 5/28.
AI Summary
On May 28, 2025, IceCure Medical Ltd. issued a press release detailing its first quarter 2025 financial results. The report, filed as a Form 6-K, includes information incorporated by reference into the company's registration statements.
Why It Matters
This filing provides investors with the latest financial performance data for IceCure Medical Ltd., crucial for assessing the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial results filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- IceCure Medical Ltd. (company) — Registrant
- May 28, 2025 (date) — Date of press release and filing
- First Quarter 2025 (date) — Period for financial results
FAQ
What type of report is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer.
What is the filing date of this report?
The filing date is May 28, 2025.
What is the primary purpose of this filing?
The primary purpose is to report the issuance of a press release titled 'IceCure Medical Reports First Quarter 2025 Financial Results'.
Which registration statements does the press release information get incorporated into?
The press release information is incorporated by reference into the Company's Registration Statements on Form S-8.
Where is IceCure Medical Ltd. located?
IceCure Medical Ltd.'s principal executive office is located at 7 Ha'Eshel St., PO Box 3163, Caesarea, 3079504, Israel.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 28, 2025 regarding IceCure Medical Ltd. (ICCM).